149 related articles for article (PubMed ID: 34301478)
1. No Change in the Use of Antivenom in Copperhead Snakebites in Ohio.
Plash WB; Stolz U; Goertemoeller S; Otten EJ
Wilderness Environ Med; 2021 Sep; 32(3):315-321. PubMed ID: 34301478
[TBL] [Abstract][Full Text] [Related]
2. Predictors of FabAV use in copperhead envenomation.
Ramirez-Cueva F; Larsen A; Knowlton E; Baab K; Rainey Kiehl R; Hendrix A; Condren M; Woslager M
Clin Toxicol (Phila); 2022 May; 60(5):609-614. PubMed ID: 34989644
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Gerardo CJ; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Ryan S; Gasior M; Anderson VE; Lavonas EJ
Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
[TBL] [Abstract][Full Text] [Related]
4. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
[TBL] [Abstract][Full Text] [Related]
5. Clinically Significant Envenomation From Postmortem Copperhead (Agkistrodon contortrix).
Emswiler MP; Griffith FP; Cumpston KL
Wilderness Environ Med; 2017 Mar; 28(1):43-45. PubMed ID: 27876196
[TBL] [Abstract][Full Text] [Related]
6. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment.
Lavonas EJ; Burnham RI; Schwarz J; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Anderson VE; Ginde AA; Gerardo CJ
J Med Toxicol; 2020 Jan; 16(1):17-23. PubMed ID: 31482319
[TBL] [Abstract][Full Text] [Related]
7. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
Gerardo CJ; Vissoci JR; Brown MW; Bush SP
Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
[TBL] [Abstract][Full Text] [Related]
8. Marked Hypofibrinogenemia and Gastrointestinal Bleeding After Copperhead (Agkistrodon contortrix) Envenomation.
Kopec KT; Yen M; Bitner M; Evans CS; Gerardo CJ
Wilderness Environ Med; 2015 Dec; 26(4):488-90. PubMed ID: 26432425
[TBL] [Abstract][Full Text] [Related]
9. Misidentification of copperhead and cottonmouth snakes following snakebites
Cox RD; Parker CS; Cox ECE; Marlin MB; Galli RL
Clin Toxicol (Phila); 2018 Dec; 56(12):1195-1199. PubMed ID: 29792342
[TBL] [Abstract][Full Text] [Related]
10. Current management of copperhead snakebite.
Walker JP; Morrison RL
J Am Coll Surg; 2011 Apr; 212(4):470-4; discussion 474-5. PubMed ID: 21463771
[TBL] [Abstract][Full Text] [Related]
11. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients.
Anderson VE; Gerardo CJ; Rapp-Olsson M; Bush SP; Mullins ME; Greene S; Toschlog EA; Quackenbush E; Rose SR; Schwartz RB; Charlton NP; Lewis B; Kleinschmidt KC; Sharma K; Lavonas EJ
Clin Toxicol (Phila); 2019 Jan; 57(1):25-30. PubMed ID: 30175628
[TBL] [Abstract][Full Text] [Related]
12. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite.
Lepak MR; Bochenek SH; Bush SP
Ann Pharmacother; 2015 Jan; 49(1):145-9. PubMed ID: 25341425
[TBL] [Abstract][Full Text] [Related]
13. Presumed Copperhead Snakebite and Antivenom Administration in the Third Trimester.
Yano J; Zerden M; German B
Wilderness Environ Med; 2019 Dec; 30(4):446-449. PubMed ID: 31699647
[TBL] [Abstract][Full Text] [Related]
14. Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab')
Gerardo CJ; Keyler DE; Rapp-Olson M; Dart RC
Clin Toxicol (Phila); 2022 Apr; 60(4):521-523. PubMed ID: 34590543
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial.
Mullins ME; Gerardo CJ; Bush SP; Rose SR; Greene S; Quackenbush EB; Lewis B; Anderson VE; Kleinschmidt KC; Schwarz RB; Charlton NP; Toschlog EA; Sharma K; Denning DA; Lavonas EJ
South Med J; 2018 Dec; 111(12):716-720. PubMed ID: 30512122
[TBL] [Abstract][Full Text] [Related]
16. Childhood Victims of Snakebites: 2000-2013.
Schulte J; Domanski K; Smith EA; Menendez A; Kleinschmidt KC; Roth BA
Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940763
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of pain, swelling, and disability from copperhead envenomation.
Roth B; Sharma K; Onisko N; Chen T
Clin Toxicol (Phila); 2016 Mar; 54(3):271-6. PubMed ID: 26795406
[TBL] [Abstract][Full Text] [Related]
18. Management of Tissue Loss After Agkistrodon Snakebite: Appropriate Use of Crotalidae-Fab Antivenin.
Larson KW; Schaefer KR; Austin C; Norton R; Finley PJ
J Trauma Nurs; 2016; 23(3):169-72. PubMed ID: 27163225
[TBL] [Abstract][Full Text] [Related]
19. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population.
Gerardo CJ; Evans CS; Kuchibhatla M; Mando-Vandrick J; Drake WG; Yen M; Kopec K; Lavonas EJ
Acad Emerg Med; 2015 Mar; 22(3):308-14. PubMed ID: 25728451
[TBL] [Abstract][Full Text] [Related]
20. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation.
Gerardo CJ; Lavonas EJ; McKinney RE
Clin Trials; 2014 Oct; 11(5):560-4. PubMed ID: 25055811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
